Obstacles remain before the world reaches the point of eliminating AIDS, but new prevention technologies and outreach programs are reasons to be optimistic about the future.
The diminished power of the immune system in older adults is usually blamed on the aging process. A new study shows that decades of inhaled particulates due to air pollution also take a toll.
Initial reports of the bivalent booster’s effectiveness have created confusion among the public. David Ho discusses his own results, the bottom line, and what to expect from COVID this winter.
A Columbia neuroscientist and psychiatrist is peering into brain cells for clues that may explain how COVID-19 can lead to depression, anxiety, psychosis, and suicide.
Mailman's ICAP program is well-known for its efforts in fighting HIV, malaria, and TB around the world, but they're also busy in the fight against COVID-19 in nearby Harlem and Bronx neighborhoods.
With $16 million gift, Columbia will open a new center for Lyme and other tick-borne diseases this summer, offering patients specialized care and expanding research at a national level.
SARS-CoV-2, the virus that causes COVID-19, does not infect brain cells but can inflict significant neurological damage, according to a new study of dozens of deceased patients.
With more patients complaining of lingering and chronic effects from COVID-19, Columbia experts review what’s known and why care for long-haulers requires an interdisciplinary approach.
Kellie Bryant, DNP, and Robert Fullilove, EdD, discussed myths and facts about the COVID-19 vaccine at a virtual event organized by the Williamsbridge branch of the NAACP.
A real-time study of immune responses inside the lungs of COVID patients suggests a cytokine “hurricane” in the airways drives severe disease, and an influx of T cells may be critical to survival.